Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020438 (
hypercalciuria
)
2,502
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Chromosome assignments for the genes encoding human renal high affinity Na/phosphate co-transporters
NaPi-3
and NPT-1 were derived by analyzing somatic cell hybrid DNAs. Polymerase chain reaction (PCR), using primers specific for two human Na/Pi co-transporters demonstrated that the genes for
NaPi-3
was assigned to human chromosome 5 while that for NPT-1 was assigned to human chromosome 6. Renal phosphate transporter genes may be candidates for causing hereditary hypophosphatemia with
hypercalciuria
in humans.
...
PMID:Chromosome assignments of genes for human Na(+)-dependent phosphate co-transporters NaPi-3 and NPT-1. 757 May 93
Genetic factors are important determinants for kidney stone formation. Cystinuria, primary hyperoxaluria, and X-linked nephrolithiasis (Dent's disease) are monogenic kidney stone diseases for which responsible genes have been identified. Familial stone disease with hyperuricosuria or renal tubular acidosis has been described in several clinical settings. Idiopathic hypercalciuria is the most common stone risk factor, and evidence in humans and in a rat model indicates that
hypercalciuria
is a complex, polygenic trait. Some candidate genes for idiopathic
hypercalciuria
are suggested by the known physiology, including those encoding the vitamin D receptor, the 1 alpha-hydroxylase of vitamin D, the calcium-sensing receptor, the
renal sodium-dependent phosphate transporter
, and chloride channels, but others remain to be identified. The multifaceted physiology of
hypercalciuria
may reflect the combined effects of polymorphisms in several genes.
...
PMID:Nephrolithiasis. 1043 76